141 related articles for article (PubMed ID: 34980880)
21. The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
Viganò L; Branciforte B; Laurenti V; Costa G; Procopio F; Cimino M; Del Fabbro D; Di Tommaso L; Torzilli G
Ann Surg Oncol; 2022 Sep; 29(9):5515-5524. PubMed ID: 35687176
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumour cells are associated with histopathological growth patterns of colorectal cancer liver metastases.
Meyer YM; Wilting SM; Kraan J; Olthof P; Vermeulen P; Martens J; Grünhagen DJ; Sleijfer S; Verhoef C
Clin Exp Metastasis; 2023 Feb; 40(1):69-77. PubMed ID: 36326981
[TBL] [Abstract][Full Text] [Related]
23. Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases.
Hu M; Chen Z; Hu D; Xi S; Wang D; Zhang X; Fong WP; Wen L; Cai Y; Yuan Y; Li B; Wu X; Lu Z; Chen G; Li L; Ding P; Pan Z; Wan D; Du Z; Chen M; Li Y
Front Immunol; 2022; 13():1045329. PubMed ID: 36591262
[TBL] [Abstract][Full Text] [Related]
24. Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.
Henault D; Stephen D; St-Hilaire PA; Messaoudi N; Vandenbroucke-Menu F; Simoneau E; Rong Z; Plasse M; Létourneau R; Roy A; Dagenais M; Lapointe R; Nguyen B; Mes-Masson AM; Soucy G; Turcotte S
Oncoimmunology; 2023; 12(1):2253642. PubMed ID: 37720689
[TBL] [Abstract][Full Text] [Related]
25. Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study.
Höppener DJ; Galjart B; Nierop PMH; Buisman FE; van der Stok EP; Coebergh van den Braak RRJ; van Amerongen MJ; Balachandran VP; Jarnagin WR; Kingham TP; Doukas M; Shia J; Nagtegaal ID; Vermeulen PB; Koerkamp BG; Grünhagen DJ; de Wilt JHW; D'Angelica MI; Verhoef C
JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34056541
[TBL] [Abstract][Full Text] [Related]
26. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
27. Histopathological growth patterns of colorectal liver metastasis exhibit little heterogeneity and can be determined with a high diagnostic accuracy.
Höppener DJ; Nierop PMH; Herpel E; Rahbari NN; Doukas M; Vermeulen PB; Grünhagen DJ; Verhoef C
Clin Exp Metastasis; 2019 Aug; 36(4):311-319. PubMed ID: 31134394
[TBL] [Abstract][Full Text] [Related]
28. Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases.
Wood CS; Pennel KAF; Leslie H; Legrini A; Cameron AJ; Melissourgou-Syka L; Quinn JA; van Wyk HC; Hay J; Roseweir AK; Nixon C; Roxburgh CSD; McMillan DC; Biankin AV; Sansom OJ; Horgan PG; Edwards J; Steele CW; Jamieson NB
Cancer Res; 2023 Apr; 83(8):1329-1344. PubMed ID: 37057593
[TBL] [Abstract][Full Text] [Related]
29. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
[TBL] [Abstract][Full Text] [Related]
30. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
31. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of infracentimetric colorectal liver metastases.
Frosio F; Cervantes B; Nassar A; Faermark N; Sanou Y; Bonnet S; Lefevre M; Louvet C; Gayet B; Fuks D
Langenbecks Arch Surg; 2022 Aug; 407(5):1971-1980. PubMed ID: 35347398
[TBL] [Abstract][Full Text] [Related]
33. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
34. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of histological categorization of desmoplastic reaction in colorectal liver metastases.
Ao T; Kajiwara Y; Yonemura K; Shinto E; Mochizuki S; Okamoto K; Aosasa S; Ueno H
Virchows Arch; 2019 Sep; 475(3):341-348. PubMed ID: 31076902
[TBL] [Abstract][Full Text] [Related]
36. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
[TBL] [Abstract][Full Text] [Related]
37. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
[TBL] [Abstract][Full Text] [Related]
38. Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
Cremolini C; Milione M; Marmorino F; Morano F; Zucchelli G; Mennitto A; Prisciandaro M; Lonardi S; Pellegrinelli A; Rossini D; Bergamo F; Aprile G; Urbani L; Morelli L; Schirripa M; Cardellino GG; Fassan M; Fontanini G; de Braud F; Mazzaferro V; Falcone A; Pietrantonio F
Br J Cancer; 2018 Apr; 118(7):955-965. PubMed ID: 29531324
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]